Component Type: Session
Level: Intermediate
While decentralized clinical trials have become more popular than ever, key considerations are often overlooked. On the surface, patients experience a number of benefits, including reduced travel times, increased access, and fewer absences from work and school. But in the midst of this expanded freedom, without proper training, support, and lifestyle considerations, patients may have suboptimal experiences that potentially threaten data quality. Join ERT’s Matt McCarty, Chief Strategy & Marketing Officer, and Madeline Geday, Senior Director, Head of Patient Experience, Illingworth Research Group’s Juliet Hulse, Senior Director of Global Research, Nurse Strategy and Patient Advocacy, and Adam Bowers, Patient and Independent Consultant, to learn about:
- Challenges that patients in decentralized clinical trials are facing
- How to overcome common “blind spots” in the decentralized clinical trial experience
- Opportunities to put the patient at the center while maintaining a focus on data quality and compliance
- A patient’s perspective in utilizing decentralized technology for research
Chair ERT
